Who owns CVS HEALTH Corp?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of CVS from SEC Form 13F filings across 2,064 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-06-30 reporting period, 2,064 institutions disclosed 1.14B shares of CVS HEALTH Corp worth $118.65B — about 88.9% of shares outstanding; the largest disclosed holder is BlackRock, Inc.. Source: SEC Form 13F filings, parsed by EvidInvest.
2,064
13F holders
$118.65B
value, 2026 filers
88.9%
of shares outstanding (1.14B sh)
352
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30 · % of fund = share of the manager's own book · % of co. = share of CVS's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | BlackRock, Inc. | 123.2M | $12.75B | 0.2% | 9.6% | -2.1% |
| 2 | VANGUARD CAPITAL MANAGEMENT LLC | 83.3M | $8.62B | 0.2% | 6.5% | +0.8% |
| 3 | Capital World Investors | 75.0M | $7.75B | 0.9% | 5.9% | -3.0% |
| 4 | STATE STREET CORP | 60.3M | $6.24B | 0.2% | 4.7% | +1.6% |
| 5 | Dodge & Cox | 50.0M | $5.17B | 2.7% | 3.9% | -3.4% |
| 6 | WELLINGTON MANAGEMENT GROUP LLP | 33.8M | $3.50B | 0.6% | 2.6% | +49.8% |
| 7 | GEODE CAPITAL MANAGEMENT, LLC | 29.9M | $3.08B | 0.2% | 2.3% | +1.5% |
| 8 | FMR LLC | 28.9M | $2.99B | 0.1% | 2.3% | -7.3% |
| 9 | VANGUARD PORTFOLIO MANAGEMENT LLC | 26.6M | $2.76B | 0.1% | 2.1% | +2.5% |
| 10 | Capital Research Global Investors | 24.3M | $2.52B | 0.4% | 1.9% | +21.6% |
| 11 | PRICE T ROWE ASSOCIATES INC /MD/ | 24.2M | $2.50B | 0.3% | 1.9% | +1.8% |
| 12 | BANK OF AMERICA CORP /DE/ | 23.2M | $2.40B | 0.2% | 1.8% | +148.0% |
| 13 | JPMORGAN CHASE & CO | 22.1M | $2.29B | 0.1% | 1.7% | -25.1% |
| 14 | Invesco Ltd. | 20.6M | $2.13B | 0.2% | 1.6% | -18.1% |
| 15 | MORGAN STANLEY | 18.6M | $1.92B | 0.1% | 1.5% | +4.4% |
| 16 | NORGES BANKNEW | 18.0M | $1.87B | 0.2% | 1.4% | new |
| 17 | Capital International Investors | 15.4M | $1.59B | 0.3% | 1.2% | 0.0% |
| 18 | GOLDMAN SACHS GROUP INC | 13.4M | $1.39B | 0.1% | 1% | +6.1% |
| 19 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 13.3M | $1.37B | 0.2% | 1% | -3.0% |
| 20 | Davis Selected Advisers | 11.9M | $1.23B | 5.3% | 0.9% | -3.1% |
| 21 | PZENA INVESTMENT MANAGEMENT LLC | 11.8M | $1.22B | 3.6% | 0.9% | -14.5% |
| 22 | NORTHERN TRUST CORP | 11.5M | $1.19B | 0.1% | 0.9% | -1.5% |
| 23 | FRANKLIN RESOURCES INC | 10.0M | $1.03B | 0.2% | 0.8% | +60.0% |
| 24 | Legal & General Group Plc | 9.2M | $948.9M | 0.2% | 0.7% | -3.6% |
| 25 | Bank of New York Mellon Corp | 9.0M | $932.5M | 0.2% | 0.7% | -0.2% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.